Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and Tamoxifen (TAM) for Estrogen Receptor (ER)-negative breast cancer cell line MDA-MB-231

2002 ◽  
Vol 38 (11) ◽  
pp. S56
Author(s):  
T Koga
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cell Line ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Breast Cancer Cell Line ◽  
Experimental Studies ◽  
Cancer Cell Line ◽  
Combined Use

scholarly journals Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7

Oncogene ◽  
2003 ◽  
Vol 22 (32) ◽  
pp. 5011-5020 ◽  
Author(s):  
Yoko Omoto ◽  
Hidetaka Eguchi ◽  
Yuri Yamamoto-Yamaguchi ◽  
Shin-ichi Hayashi
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cell Line ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Breast Cancer Cell Line ◽  
Cancer Cell Line

ChIP-seq predicted estrogen receptor biding sites in human breast cancer cell line MCF7

Tumor Biology ◽  
2014 ◽  
Vol 35 (5) ◽  
pp. 4779-4784 ◽  
Author(s):  
Qi Li ◽  
Huichun Wang ◽  
Leyang Yu ◽  
Jun Zhou ◽  
Jingde Chen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cell Line ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Breast Cancer Cell Line ◽  
Human Breast Cancer ◽  
Cancer Cell Line ◽  
Human Breast Cancer Cell ◽  
Human Breast

scholarly journals Estrogen receptor   inhibits 17 -estradiol-stimulated proliferation of the breast cancer cell line T47D

2004 ◽  
Vol 101 (6) ◽  
pp. 1566-1571 ◽  
Author(s):  
A. Strom ◽  
J. Hartman ◽  
J. S. Foster ◽  
S. Kietz ◽  
J. Wimalasena ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Estrogen Receptor ◽  
Cell Line ◽  
Cancer Cell ◽  
Breast Cancer Cell ◽  
Breast Cancer Cell Line ◽  
Cancer Cell Line
Sign in / Sign up

Export Citation Format

Share Document